Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
| $257M | 0.12% |
639,700
-132,400
| -17% | -$53.1M |
|
127
PUT
JPMorgan Chase
JPM
$935B
| $257M | 0.12% |
3,853,600
-639,400
| -14% | -$41.7M |
|
128
PUT
McDonald's
MCD
$192B
| $256M | 0.12% |
2,220,400
-2,115,400
| -49% | -$251M |
|
129
CALL
Goldman Sachs
GS
$303B
| $254M | 0.12% |
1,575,100
-541,200
| -26% | -$88M |
|
130
PUT
iShares MSCI Brazil ETF
EWZ
$8.52B
| $253M | 0.12% |
7,510,500
-95,100
| -1% | -$3.15M |
|
131
PUT
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.1B
| $253M | 0.12% |
2,056,100
+1,968,200
| +2,239% | +$242M |
|
132
CALL
Walmart Inc
WMT
$825B
| $252M | 0.12% |
10,502,100
-4,224,900
| -29% | -$102M |
|
133
PUT
iShares Biotechnology ETF
IBB
$10.7B
| $248M | 0.12% |
2,573,700
-1,675,800
| -39% | -$159M |
|
134
PUT
Lockheed Martin
LMT
$130B
| $248M | 0.12% |
1,033,200
+558,400
| +118% | +$140M |
|
|
MON
135
CALL
DELISTED
Monsanto Co
MON
| $246M | 0.12% |
2,407,300
-908,100
| -27% | -$95.3M |
|
136
Booking.com
BKNG
$158B
| $244M | 0.12% |
4,137,075
+1,407,775
| +52% | +$78.5M |
|
137
CALL
American Airlines Group
AAL
$9.15B
| $243M | 0.12% |
6,629,700
+198,400
| +3% | +$7.01M |
|
|
138
Bristol-Myers Squibb
BMY
$137B
| $240M | 0.12% |
+4,459,411
| New | +$286M |
|
139
CALL
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| $240M | 0.12% |
6,795,200
+28,000
| +0.4% | +$959K |
|
140
PUT
Charter Communications
CHTR
$17.9B
| $239M | 0.12% |
884,000
-164,000
| -16% | -$41.4M |
|
141
PUT
Starbucks
SBUX
$122B
| $236M | 0.11% |
4,355,400
+1,219,700
| +39% | +$68.2M |
|
142
CALL
Home Depot
HD
$335B
| $234M | 0.11% |
1,821,800
+197,200
| +12% | +$26.3M |
|
143
CALL
iShares China Large-Cap ETF
FXI
$4.28B
| $234M | 0.11% |
6,157,100
-4,281,600
| -41% | -$157M |
|
144
PUT
Nike
NKE
$60.5B
| $226M | 0.11% |
4,286,300
-466,800
| -10% | -$26.4M |
|
145
PUT
NVIDIA
NVDA
$5.2T
| $221M | 0.11% |
128,876,000
+15,364,000
| +14% | +$22.7M |
|
146
PUT
United Parcel Service
UPS
$86.8B
| $221M | 0.11% |
2,017,500
-643,200
| -24% | -$70.3M |
|
147
PUT
Teva Pharmaceuticals
TEVA
$43.5B
| $219M | 0.11% |
4,764,800
+1,124,300
| +31% | +$58.7M |
|
148
CALL
SLB Ltd
SLB
$79.9B
| $219M | 0.11% |
2,780,700
+199,800
| +8% | +$15.9M |
|
149
PUT
Verizon
VZ
$205B
| $217M | 0.1% |
4,180,300
-1,421,100
| -25% | -$76.3M |
|
150
CALL
Union Pacific
UNP
$183B
| $216M | 0.1% |
2,218,200
-403,400
| -15% | -$37.7M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.